Latest Articles

The coronavirus outbreak looks set-in for the long haul, with new strong holds and cases cropping in a constant stream. A question mark has also been raised over the possibility of re-infection. Officials and health authorities are doing their best to try and limit the spread but it requires the cooperation of the public.

The integration of data into pharma and healthcare has created the opportunity to delve deep into the real world and generate meaningful insights, optimize patient recruitment, develop a better understanding of various therapeutics, and directly improve patient outcomes.

A new system named “Hopcroft” has brought advanced new data generation and processing capabilities to researchers and artists at Northern Illinois University. In this article, we discover how high-performance computing (HPC) has helped power-up "Hopcroft".

Three dimensional (3D) bioprinting and artificial intelligence (AI) have been fundamental technologies for understanding disease and contributing to groundbreaking research. Within the past year, technological developments have provided opportunities for early diagnosis and targeted treatment for mesothelioma patients.

Throughout human history, we have always been at war with infectious agents. In the past, there used to be less sophisticated tools to identify epidemics. Nowadays, more advanced technologies, such as genomic sequencing, are being harnessed to gain information about infectious agents.

Academic publishing has proved stubbornly resistant to change, but preprint servers have started to make their mark. Technology Networks spoke to BiorXiv content lead Samantha Hindle to find out more about how preprints could shake up publishing and give scientists a new avenue through which to share their research.

Like other industries across the economy, healthcare saw new developments in technology through 2019. Now, as big tech becomes more interested in the industry and looks for ways to partner with hospitals and other medical institutions, these changes are likely to deepen — and they may even transform how these organizations operate.

Bringing new medicines to patients struggling with serious illness is the driving force behind drug discovery and development. This article highlights advances in three technology areas that show great promise to speed the drug discovery and development process.

This article will explain when it is appropriate to use a paired t-test versus an unpaired t-test, as well as the hypothesis and assumptions of each.

The short answer is, in terms of deaths at least, the current coronavirus outbreak is not as bad as it was initially predicted. However, researchers are working tirelessly as new data becomes available to refine models vital for disease management.